Date: March 18, 2021 | Time: 19:00 - 21:00 (CET)
Moderated by: Prof. A. Davenport (Hospital UK)
Evolution of anticlotting strategies over time
Prof. I. Elalamy (France): Hemostasis in severe renal impaired patient : how to limit thrombotic and bleeding risks?
- Prof. Z. Massy (France): Heparin during dialysis: A friend or a foe?
Analysis of dialyzer clotting: Going beyond the limits of the human eye
Prof. M. Bonomini (Italy): Proteomic technologies shed light on the interactions between the dialyzer membrane and the blood of the patient.
- Prof. W. Van Biesen (Belgium): Development of a quantitative assay for dialyzer clotting and how it allows for the comparison of anticlotting strategies.
How do the latest anticlotting strategies perform in practice?
- Prof. B. Meijers (Belgium): Dialysis without systemic anticoagulation, is it possible?
- Dr. A.L. Garcia Herrera (Spain): Heparin-free dialysis in practice.